# Dev Session Log — 2026-07-03 (reserve-basis exactness, Slice 2)

## Item Selected
- **Source:** CONTINUATION_reserve_basis_exactness.md (active Epic) — Slice 2.
- **Priority:** IMPORTANT (Reserve-Basis Exactness epic, constituted from the two
  surviving IMPORTANT reserve residuals in PRODUCT_DIRECTION_2026-06-18).
- **Title:** Surface `valuation_mortality` end-to-end (config / CLI / API + 2001
  CSO integration + notebook).
- **Slice:** 2 of 4.
- **Branch:** `claude/loving-gauss-ipkczw`

## Baseline
`make test` at session start: **1940 passed, 0 failures, 110 deselected**
(matches the recorded Slice-1 post-refactor baseline). `convert_soa_tables.py`
produced the VBT/CSO tables; the four CIA tables report MISSING from pymort
(known-standing, no test depends on them). No new or changed failures → PROCEED.

## Ledger Healing (step 4b)
Only PR #124 merged since the prior session log — it is Slice 1 of the active
epic (in progress), not a completed PRODUCT_DIRECTION item, so no SHIPPED
crossout is due. Ledger already healed for B3 in the Slice-1 session.

## Selection Rationale
Step 5 found the active Epic's CONTINUATION IN PROGRESS with Slice 1 merged
(PR #124, verified merged). The CONTINUATION IS the work selection; Slice 2 is
NEXT and its dependency (Slice 1 merged) is satisfied, so per the active-epic
rule the session advanced Slice 2 — no fallback pick considered.

## Verify Premise (step 7b)
Reproduced before coding: a `golden_config_flat` config carrying
`deal.valuation_mortality: "CSO_2001"` (with `reserve_basis: CRVM`) left
`assumptions.valuation_mortality` `None` and `inputs.deal` had no
`valuation_mortality` attribute — the config parser dropped the key silently and
neither the CLI nor the API exposed it. Premise holds: the epic's headline
capability was unreachable on the deal path.

## Decomposition Plan
| Slice | Scope | Status | PR |
|-------|-------|--------|----|
| 1 | `valuation_mortality` slot + CRVM/VM-20-NPR wiring (Term + WL) | ✅ Done | #124 |
| 2 | Surface end-to-end: config / CLI / API + 2001 CSO + notebook | ✅ Done | this PR |
| 3 | GAAP (FAS 60) basis for TermLife (design ADR + closed-form test) | ⏳ Next | — |
| 4 | GAAP (FAS 60) for WholeLife + epic close | 🔲 Planned | — |

## What Was Done
Added `DealConfig.valuation_mortality: str | None = None` — a **named mortality
source id** (`"CSO_2001"` / `"SOA_VBT_2015"` / `"CIA_2014"` / `"flat"`), the
config/CLI/API-friendly equivalent of the `MortalityTable` object Slice 1 put on
`AssumptionSet`. A new shared public helper `load_valuation_mortality(source,
data_dir)` (in `core/pipeline.py`) reuses the projection-table source resolution
but applies **no** pricing multiplier and **no** improvement — the prescribed
valuation table is static (ADR-125). `build_assumption_set` calls it when the
deal field is set (else leaves the slot `None`, byte-identical). The REST API
calls the same helper directly, so the pipeline and the API resolve the table
identically.

CLI: a `--valuation-mortality` flag on `polaris price` with flag-over-config
precedence (threaded via `_build_pipeline_from_config(valuation_mortality_override=...)`),
`deal.valuation_mortality` parsing in both the nested and legacy config schemas,
and a **conditional** JSON `summary` echo (present only when set → runs without
it stay byte-identical, no always-present `null`). API: a `PriceRequest.valuation_mortality`
field loaded server-side from `$POLARIS_DATA_DIR/mortality_tables`; an unknown id
raises `PolarisValidationError` → HTTP 422. Notebook `02` gains a section pricing
CRVM on a conservative **prescribed** table vs the best-estimate table, with
embedded asserts (the prescribed table moves CRVM; `NET_PREMIUM` ignores it),
using a synthetic table so it runs without the converted CSVs. Recorded in
ADR-126.

Verified end-to-end: on the golden flat block, WL cedant PV Profits under CRVM
are $3,233,215 on the projection best-estimate table vs $647,977 on the 2001 CSO
prescribed table — the prescribed table drives the statutory reserve, as
intended. Default (no field) is byte-identical: golden `flat` reproduces
Reinsurer $45,386 / Cedant $3,513,563 exactly, with no `valuation_mortality`
summary key.

## Files Changed
- `src/polaris_re/core/pipeline.py` — `DealConfig.valuation_mortality`,
  `load_valuation_mortality` (new export), `build_assumption_set` threading.
- `src/polaris_re/cli.py` — `--valuation-mortality` flag; config parsing (nested
  + legacy); `valuation_mortality_override` on `_build_pipeline_from_config`;
  conditional `summary` echo.
- `src/polaris_re/api/main.py` — `PriceRequest.valuation_mortality`;
  `_build_components` param + server-side load; `price` endpoint threading;
  `load_valuation_mortality` import.
- `notebooks/02_reserve_basis_comparison.ipynb` — prescribed-valuation-table
  section (synthetic, CI-safe, embedded asserts).
- `docs/DECISIONS.md` — ADR-126.
- `docs/CONTINUATION_reserve_basis_exactness.md` — Slice 2 → DONE, Slice 3 → NEXT;
  resolved CSV-path open question.
- `docs/PLAN_reserve_basis_exactness.md` — status; Slice 2 → DONE, Slice 3 → NEXT.
- `docs/PRODUCT_DIRECTION_2026-06-18.md` — 2 promoted follow-ups (ADR-126).
- `docs/DEV_SESSION_LOG_2026-07-03_reserve_basis_exactness_slice2.md` — this log.

## Tests Added
- `tests/test_core/test_pipeline_valuation_mortality.py` — 7 tests: loader
  (flat, unknown-raises, named CSO); `build_assumption_set` default `None`,
  attachment, **pricing-multiplier isolation** (`multiplier=2.0` → projection q
  0.002, valuation q 0.001), unknown-source raise.
- `tests/test_cli_valuation_mortality.py` — 8 tests: no summary key by default,
  flag echo, CRVM-on-CSO ≠ CRVM-on-projection-table (WL cohort), `NET_PREMIUM`
  ignores the slot, unknown-source non-zero exit, config-field honoured,
  flag-over-config, default config has no field.
- `tests/test_api/test_valuation_mortality.py` — 5 tests: omitted accepted,
  omitted ≡ explicit null, CRVM-on-CSO moves the number, `NET_PREMIUM` ignores
  the slot, unknown-source 422.
- `tests/test_notebooks/test_reserve_basis_notebook.py` — execution guard for
  notebook `02` (the embedded asserts are the checks).
- CSO-dependent tests are `requires_cso`-gated (skipped when the converted 2001
  CSO CSVs are absent); the multiplier-isolation, byte-identity, and
  unknown-source paths use the synthetic `"flat"` source and always run.

## Acceptance Criteria
| Criterion | Status | Notes |
|-----------|--------|-------|
| `deal.valuation_mortality` / `--valuation-mortality` / API field values CRVM on the prescribed table | ✅ | WL CRVM $3.23M (proj) vs $648K (CSO); API round-trip moves the number |
| Named-source loader shared by pipeline + API | ✅ | `load_valuation_mortality`, unknown id → PolarisValidationError / 422 |
| Flag overrides config | ✅ | `test_flag_overrides_config` |
| Static valuation table (no pricing multiplier) | ✅ | multiplier-isolation test |
| `NET_PREMIUM` ignores the slot | ✅ | CLI + API tests |
| Omitting the key byte-identical on all goldens | ✅ | golden flat exact ($45,386 / $3,513,563); QA 76 green; no summary key |
| Notebook demonstrates the prescribed-table path | ✅ | execution guard green |

## Open Questions / Follow-ups
- **CSV-path escape hatch** for an arbitrary cedant valuation table (named-source
  id only today) — promoted NICE-TO-HAVE (ADR-126 Out of scope, 1st-order).
- **Echo the prescribed table on the API response / Excel / dashboard** (CLI
  summary only today) — promoted NICE-TO-HAVE (ADR-126 Out of scope, 1st-order).
- Successor COMMERCIAL_VIABILITY_REVIEW still due ~2026-07-18 (carried from the
  Slice-1 log): the 2026-06-18 review's epic queue is exhausted, so the epic
  after Reserve-Basis Exactness has no ranked source — regenerate the review at
  the 30-day mark (or earlier if this epic finishes first).

## Parked Polish
None. Both harvested items are 1st-order follow-ups of the originally-planned
Slice-2 surfacing and were promoted normally (NICE-TO-HAVE).

## Impact on Golden Baselines
None — `deal.valuation_mortality` defaults to `None` and no golden config sets
it, so every priced number is byte-identical. Golden `flat` reproduces Total PV
Profits Reinsurer $45,386 / Cedant $3,513,563 exactly, with no
`valuation_mortality` summary key. No baseline regeneration.
